Interactive case session using PredictND tool

Similar documents
Advances in Alzheimer s diagnosis; implications for clinical practice. Wiesje M. van der Flier Alzheimer Europe Conference Berlin, 4 October 2017

P20.2. Characteristics of different types of dementia and challenges for the clinician

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Form D1: Clinician Diagnosis

Brain imaging for the diagnosis of people with suspected dementia

Neuro degenerative PET image from FDG, amyloid to Tau

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER

Common Forms of Dementia Handout Package

2016 Programs & Information

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

What is dementia? What is dementia?

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

The ABCs of Dementia Diagnosis

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health

Non Alzheimer Dementias

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

Part 2: Early detection, assessment and treatment in relation to the new guidelines. Christopher Patterson McMaster University

Assessing and Managing the Patient with Cognitive Decline

Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

What is dementia? What is dementia?

DEMENTIA NEWSLETTER FOR PHYSICIANS

Neuro-Imaging in dementia: using MRI in routine work-up Prof. Philip Scheltens

Mild Cognitive Impairment (MCI)

Silent Cerebral Strokes: Clinical Outcomes and Management

Type 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease

Alzheimer s Disease Update: From Treatment to Prevention

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Clinical Genetics & Dementia

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

I do not have any disclosures

Clinical Differences Among Four Common Dementia Syndromes. a program of Morningside Ministries

! slow, progressive, permanent loss of neurologic function.

Diagnosis and Treatment of Alzhiemer s Disease

Dementia and Delirium: A Neurologist s Approach to Altered Mental Status. Case 1 4/7/11. Which of the following evaluations is your next step?

FRONTOTEMPORAL DEMENTIA

Biomarkers: Translating Research into Clinical Practice

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

Making dementia a European priority

Evaluation and Treatment of Dementia

Recent publications using the NACC Database. Lilah Besser

Alzheimer s Disease Neuroimaging Initiative

Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician

Outline. Facts and figures Action plans Early / correct diagnosis Conclusions

Piramal Imaging to Present New Research in PET Imaging at Society of Nuclear Medicine and Molecular Imaging 2017 Annual Meeting

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer s disease presented at AAIC 2018

MRI Hippocampal Volume for Enrichment

Carol Manning, PhD, ABPP-CN Director, Memory Disorders Clinic University of Virginia

Il processo diagnostico dell Alzheimer dalla clinica al neuroimaging Giovanni B. Frisoni M.D.

Alzheimer s Disease - Dementia

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

DEMENTIA ANDREA BERG, MD

Amsterdam Dementia Cohort: Performing Research to Optimize Care

UDS version 3 Summary of major changes to UDS form packets

10 Facts We All Need to Know About Dementia (MNCD) in Old Age

7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER FOURTEEN CHAPTER OUTLINE. Dementia, Delirium, and Amnestic Disorders. Oltmanns and Emery

Early Onset Dementia From the background to the foreground

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

BHIVA Best Practice Management Session

Diagnosing & Dealing with Dementia

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Differential Diagnosis

Claims & Underwriting. You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association

OLD AGE PSYCHIATRY. Dementia definition TYPES OF DEMENTIA. Other causes. Psychiatric disorders of the elderly. Dementia.

Regulatory Challenges across Dementia Subtypes European View

review of existing studies on ASL in dementia Marion Smits, MD PhD

What APS Workers Need to Know about Frontotemporal, Lewy Body and Vascular Dementias

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

SECTION 1: as each other, or as me. THE BRAIN AND DEMENTIA. C. Boden *

Assessing Cognition. Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin

NCFE Level 2 Certificate in The Principles of Dementia Care

What is. frontotemporal. address? dementia?

European Prevention of Alzheimer s Dementia (EPAD)

Dementia Awareness Handout

Learning Outcomes. To have a clear understanding of the term dementia, and current facts and statistics relating to dementia.

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

MOVEMENT DISORDERS AND DEMENTIA

Recognizing Dementia can be Tricky

The prevalence of YOD increases almost exponentially with age (as does the prevalence of late onset dementia).

Dementia, Cognitive Aging Services and Support

Dementia Past, Present and Future

Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation

Response Ratio Female % Male % No Response(s) 1 <1 % Totals %

Latest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice

Dementia: It s Not Always Alzheimer s

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH

Update on functional brain imaging in Movement Disorders

An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease

CAREGIVER SUMMIT. The PD You Can't See: Dealing with Non-Motor Symptoms. Kaitlyn Roland, PhD. Sponsored by:

8/24/18. Dementia. Risk of Dementia Following Traumatic Brain Injury: A Review of the Literature. Media Presence. Media Presence

Dementia is an overall term for a set of symptoms that is caused by disorders affecting the brain.

Transcription:

Interactive case session using PredictND tool AEC 2017, Berlin, Germany Hanneke Rhodius- Meester Clinical geriatrician VUmc Alzheimer Center, Amsterdam h.rhodius@vumc.nl

Disclosures The Alzheimer Center VUmc has received unrestricted funding from: Aegon, Alzheimer Nederland, VUmc Fonds, Heineken Nederland, Kroonenberg NV, Rabobank Amsterdam, Genootschap tot Steun Alzheimercentrum, Alzheimer Rally, and many others Contract research partners: GE Healthcare, Piramal Imaging, Merck, Nutricia, Probiodrug, EIP Pharma, Roche AG Espria, Combinostics, and Boehringer Ingelheim Grant funding: NWO, ZonMW, CVON, EU-FP7, EU-JPND, EU-IMI, ISAO, Alzheimer Nederland, Dioraphte, Gieskes Strijbis Dr Rhodius receives no personal compensation from any of the above or others except the Vumc; she is appointed on a grant from the European Seventh Framework Program project PredictND under grant agreement 611005.

Dementia diagnosis. Background

Background Dementia diagnosis.complex! Challenge as a clinician How to take into account all information? How to weigh and combine data? And. Literature often about controls vs Alzheimer Clinical practice is about differential diagnosis

Background To clinical practice. 73 year old male: History: transient ischemic attack Memory and word finding problems since 3 years, plus subtle hallucinations Mild parkinsonism, MMSE 28/30 Impairment in memory, naming and executive functions, slow MRI: mild atrophy and mild vascular damage No CSF obtained???

Background To clinical practice. 73 year old male: History: transient ischemic attack Memory and word finding problems since 3 years, plus subtle hallucinations Mild parkinsonism, MMSE 28/30 Impairment in memory, naming and executive functions, slow MRI: mild atrophy and mild vascular damage No CSF obtained Lewy body dementia? Alzheimer s disease?

Aim Could a computer tool help? Combining and visualizing data providing overview Dealing with conflicting data like clinical practice Comparing different dementia types with each other about differential diagnosis clinical practice is Mattila 2012, Antilla 2013, Rhodius- Meester 2016

Methods PredictND project computer tool Clinical descision support system: Combines and visualizes data to support clinician Entrance patient data Analyses tool How? Entrance baseline data of 1 patient: - demographics - CSF - cognitive tests - raw MRI images Outcome DSI and fingerprint

Methods Automatic MRI analyses Clinical practice: Majority of information hidden in MRI How to extract? With tool: Provides simple overview Highlights important areas Quantitative features, f.e. - hippocampal volumes Entrance patient data Analyses tool Outcome DSI and fingerprint Koikkalainen, NeuroImage Clin 2016

Methods Disease state index Compares patient baseline data with dataset Which diagnosis fits the data best? Entrance patient data Analyses tool Results in disease state index (DSI): Value between 0 and 1 cut-off 0.5 xx = 0= resembles f.e. controls xx = 1= resembles f.e. vascular dementia Outcome DSI and fingerprint

Methods Fingerprint Combines and visualises all data of 1 patient Size of box: xxxx = large contribution to diagnosis = small contribution Colour of box: xx = towards 0 (f.e. controls) xx = towards 1 (f.e. AD) Entrance patient data Analyses tool Outcome DSI and fingerprint

Translation to daily practice

Results Back to clinical practice. 73 year old male: History: transient ischemic attack Memory and word finding problems since 3 years, plus subtle hallucinations Mild parkinsonism, MMSE 28/30 Impairment in memory, naming and executive functions, slow MRI: MTA 1/1, GCA 1, Fazekas 1 all mild No CSF obtained Lewy body dementia? Alzheimer s disease?

Results 73 year old male tool Ingevoerde gegevens Ruwe MRI beelden Resultaten tool

Results 73 year old male Mixed pathology. Amyloïd-PET: positive DLB, with comorbid Alzheimer s pathology

Results 58 years old female Since 1 year complaints of forgetfulness, inappropriate behavior and urgency to speak. Interference in daily living No medical history Neuropsychology: MMSE 26/30, impairments in memory and language, difficult to stop MRI brain: atrophy frontal and temporal regions CSF: normal amyloid, tau and p-tau???

Results 58 years old female Since 1 year complaints of forgetfulness, inappropriate behavior and urgency to speak. Interference in daily living No medical history Neuropsychology: MMSE 26/30, impairments in memory and language, difficult to stop MRI brain: atrophy frontal and temporal regions CSF: normal amyloid, tau and p-tau FTLD, Alzheimer s disease?

58 year old female tool Results

Results 58 years old female Results tool DLB DSI 0.74 Behavioural variant of FTD AD DSI 0.59 xx = DLB, xx = AD

Results 71 years old female Memory complaints since 4 years, desorientation and apraxia, interference in cooking, shopping and driving. History of hypertension and diabetes medication Neuropsychology: MMSE 20/30, impairment in memory, executive functions, naming and visual functions. MRI brain: moderate hippocampal and parietal atrophy No CSF obtained???

Results 71 years old female Memory complaints since 4 years, desorientation and apraxia, interference in cooking, shopping and driving. History of hypertension and diabetes medication Neuropsychology: MMSE 20/30, impairment in memory, executive functions, naming and visual functions. MRI brain: moderate hippocampal and parietal atrophy No CSF obtained Alzheimer s dementia? Vascular dementia?

71 year old female tool Results

Results 71 years old female Results tool DLB DSI 0.74 Alzheimer s disease AD DSI 0.59 xx = DLB, xx = AD

Conclusion Assistance by computer Differential diagnosis of dementia is complex, computer tool can help by: Combining and visualising data provides overview Adding fully automated MRI analyses Multiclass tool daily practice is about differential diagnosis and multiple pathologies Yet, difficult cases will remain difficult: Tool depends on quality of data shows what you enter Can never replace the clinician only supports

v h.rhodius@vumc.nl